ad image

Company Info

Vetter Pharma International GmbH

Vetter Pharma International GmbH

CDMO

Overview

Vetter is an international specialist in the production of aseptically prefilled syringe systems, cartridges and vials. The company is family-owned, independent and does not manufacture its own drugs. Vetter's focus is on providing highly skilled support and state-of-the-art manufacturing resources - from the initial phases of clinical development and regulatory approval process through successful product launch and commercial manufacturing and life cycle management. Specifically, Vetter's offerings include primary packaging development, process development, clinical manufacturing, pharmaceutical analysis and complete commercial manufacturing services.
Vetter Pharma International GmbH
Contributions
32 Contributions1 / 2
Vetter Pharma International GmbH
Expansion

Vetter Boosts Pharmaceutical Storage Capacity with Major Warehouse Expansion

Vetter Pharma International GmbH

PR-03-25-NI-04Mar 11, 2025
Vetter Pharma International GmbH
Syringe

Vetter Introduces the Next Evolution of the V-OVS® Syringe Closure System

Vetter Pharma International GmbH

PR-01-25-NI-13Jan 14, 2025
Vetter Pharma International GmbH
senior management

Vetter Strengthens Senior Management Team for Further Sustainable Growth

Vetter Pharma International GmbH

PR-11-24-NI-117Nov 21, 2024
Vetter Pharma International GmbH
CDMO

Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)

Vetter Pharma International GmbH

PR-M01-24-01Jan 17, 2024
Vetter Pharma International GmbH

Vetter joins Science Based Targets Initiative

Vetter Pharma International GmbH

PR-M12-23-01Dec 05, 2023
Vetter Pharma International GmbH
Expansion

Vetter looks ahead to further expansions to meet supply chain demand

Vetter Pharma International GmbH

PR-M10-23-03Oct 17, 2023
Vetter Pharma International GmbH
CDMO Service and Capacity Expansion

Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing

Vetter Pharma International GmbH

PR-M05-23-01May 09, 2023
Vetter Pharma International GmbH
UN Global Compact

CDMO Joins United Nations Global Compact

Vetter Pharma International GmbH

PR-M03-23-02Mar 08, 2023
Vetter Pharma International GmbH
Clinical Manufacturing

Vetter's Clinical Facility Demonstrates Success with Five Client Products Now on the Market

Vetter Pharma International GmbH

PR-M01-23-01Feb 01, 2023
Vetter Pharma International GmbH
Warehouse Storage

New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure

Vetter Pharma International GmbH

PR-M10-22-07Oct 27, 2022
Vetter Pharma International GmbH
Site Expansion

Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills

Vetter Pharma International GmbH

PR-M06-22-07Jun 28, 2022
Vetter Pharma International GmbH
Award

Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award

Vetter Pharma International GmbH

PR-M05-22-12May 18, 2022
Vetter Pharma International GmbH
Lab Benchmarking

Top Results for Vetter in University of St. Gallen Benchmarking

Vetter Pharma International GmbH

PR-M04-22-04Apr 07, 2022
Vetter Pharma International GmbH
Manufacturing Authorization

Vetter’s New Clinical Manufacturing Site Now Officially Authorized

Vetter Pharma International GmbH

PR-M01-22-12Jan 19, 2022
Vetter Pharma International GmbH
Climate Protection

Vetter's Contribution to Climate Protection: Corporate Sites Around the World are CO2-Neutral

Vetter Pharma International GmbH

PR-M09-21-06Sep 24, 2021
Vetter Pharma International GmbH
Clinical Manufacturing

Vetter's New Clinical Manufacturing Site Now Fully Integrated

Vetter Pharma International GmbH

PR-M07-21-011-845Jul 21, 2021
Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development
Collaboration

Collaboration in Action: New Milestones Efficiency and Simplifying the Complexities of Drug Development

Peter Soelkner

Vetter Pharma International GmbH

PAO-06-21-CL-02-954Jun 09, 2021
Vetter Pharma International GmbH
Award

Vetter Once Again Wins Axia Best Managed Companies Award

Vetter Pharma International GmbH

PR-M05-21-019May 26, 2021
Vetter Pharma International GmbH
Sustainability

Vetter Continues to Implement its Long-Term Sustainability Strategy

Vetter Pharma International GmbH

PR-M11-20-029Dec 03, 2020
Vetter Pharma International GmbH
Strategy

Vetter Continues its Long-term Investment Strategy to Sustain Future Growth

Vetter Pharma International GmbH

PR-M10-20-13Oct 21, 2020
1 / 2